69 related articles for article (PubMed ID: 31179056)
1. Efficacy of perioperative chemotherapy for pulmonary high-grade neuroendocrine carcinomas: a propensity score matching analysis.
Ogawa H; Tanaka Y; Kitamura Y; Shimizu N; Doi T; Hokka D; Tane S; Nishio W; Yoshimura M; Maniwa Y
J Thorac Dis; 2019 Apr; 11(4):1145-1154. PubMed ID: 31179056
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous computed tomography-guided core needle biopsy can be used to histologically confirm the clinical features and long-term prognosis of pulmonary neuroendocrine neoplasms.
Chen C; Wang Y; Huang H; He X; Li W
Jpn J Radiol; 2023 Dec; 41(12):1414-1419. PubMed ID: 37395983
[TBL] [Abstract][Full Text] [Related]
3. Differences between Advanced Large Cell Neuroendocrine Carcinoma and Advanced Small Cell Lung Cancer: A Propensity Score Matching Analysis.
Yang W; Wang W; Li Z; Wu J; Xu X; Chen C; Ye X
J Cancer; 2023; 14(9):1541-1552. PubMed ID: 37325062
[No Abstract] [Full Text] [Related]
4. Clinical and Pathologic Differences between Small-Cell Carcinoma and Large-Cell Neuroendocrine Carcinoma of the Lung.
Fujiwara W; Yotsukura M; Yoshida Y; Nakagawa K; Kashima J; Yatabe Y; Watanabe SI
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38811497
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of surgically resected combined small cell lung cancer: a two-institutional experience.
Zhang C; Yang H; Zhao H; Lang B; Yu X; Xiao P; Zhang X
J Thorac Dis; 2017 Jan; 9(1):151-158. PubMed ID: 28203418
[TBL] [Abstract][Full Text] [Related]
6. The role of surgery in high grade neuroendocrine tumours of the lung.
Welter S; Aigner C; Roesel C
J Thorac Dis; 2017 Nov; 9(Suppl 15):S1474-S1483. PubMed ID: 29201450
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of synaptophysin, CD56, thyroid transcription factor-1, and Ki-67 in pulmonary high-grade neuroendocrine carcinomas.
He Y; Zhao L; Tang X; Jiang Q; Zhao X; Cao Y
Ann Diagn Pathol; 2024 Feb; 68():152239. PubMed ID: 38006863
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Efficacy of Chemotherapy by Addition of Immune Checkpoint Inhibitors in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung: A Real-World Analysis.
Meng L; Cao B; Ji R; Chen DT; Laber DA; Shafique M
J Cancer; 2023; 14(17):3169-3175. PubMed ID: 37928431
[No Abstract] [Full Text] [Related]
9. Advances in genetic profile and therapeutic strategy of pulmonary large cell neuroendocrine carcinoma.
Zhu S; Wang X; Li H; Zhao P; Liu J; Zhang L; Cheng Y
Front Med (Lausanne); 2024; 11():1326426. PubMed ID: 38482526
[TBL] [Abstract][Full Text] [Related]
10. Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinoma.
Kasahara N; Wakuda K; Omori S; Nakashima K; Ono A; Taira T; Kenmotsu H; Naito T; Murakami H; Mori K; Watanabe R; Endo M; Nakajima T; Yamada M; Takahashi T
Mol Clin Oncol; 2017 May; 6(5):718-722. PubMed ID: 28529747
[TBL] [Abstract][Full Text] [Related]
11. Spread Through Air Spaces in Stage I Pulmonary Large Cell Neuroendocrine Carcinoma.
Wan S; Shen Z; Hu S; Zhang L; Yu H; Chen Y; Wang J; Wang D; Zhang J; Zhang P
Ann Thorac Surg; 2024 Jan; ():. PubMed ID: 38242341
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression.
Kim HS; Kim JK; Lee JH; Lee YJ; Lee GK; Han JY
JCO Precis Oncol; 2024 Apr; 8():e2300495. PubMed ID: 38635931
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung Carcinoma.
Fisch D; Bozorgmehr F; Kazdal D; Kuon J; Klotz LV; Shah R; Eichhorn F; Kriegsmann M; Schneider MA; Muley T; Stenzinger A; Bischoff H; Christopoulos P
Front Oncol; 2021; 11():673901. PubMed ID: 34307143
[TBL] [Abstract][Full Text] [Related]
14. The outcomes of different regimens depend on the molecular subtypes of pulmonary large-cell neuroendocrine carcinoma: A retrospective study in China.
Wang Z; Wu Y; Lu T; Xu Y; Chen M; Zhong W; Zhao J; Wang M
Cancer Med; 2024 Jan; 13(1):. PubMed ID: 38180312
[TBL] [Abstract][Full Text] [Related]
15. Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis.
Ricci C; Campana D; Ingaldi C; Lamberti G; Alberici L; Tateo V; Castagna G; Ricco G; Calderaro F; Malvi D; Rosini F; Casadei R
Langenbecks Arch Surg; 2023 Jan; 408(1):65. PubMed ID: 36695921
[TBL] [Abstract][Full Text] [Related]
16. Role of surgery in high-grade neuroendocrine tumors of the lung.
Bedirhan MA; Ürer N; Seyrek Y; Arda N; Fener N; Cansever L; Kıyık M; Altın S
Turk Gogus Kalp Damar Cerrahisi Derg; 2022 Jul; 30(3):389-394. PubMed ID: 36303705
[TBL] [Abstract][Full Text] [Related]
17. Effect of Adjuvant and Palliative Chemotherapy in Large Cell Neuroendocrine Carcinoma of the Lung: A Systematic Review and Meta-Analysis.
Chen H; Ishihara M; Horita N; Kazahari H; Ochiai R; Tanzawa S; Honda T; Ichikawa Y; Watanabe K; Seki N
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885057
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches.
Lania A; Ferraù F; Rubino M; Modica R; Colao A; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():651438. PubMed ID: 34381421
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I-IV Stage.
Lowczak A; Kolasinska-Cwikla A; Osowiecka K; Glinka L; Palucki J; Rzepko R; Doboszynska A; Cwikla JB
Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33525370
[No Abstract] [Full Text] [Related]
20. DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC.
Ogawa H; Sakai Y; Nishio W; Fujibayashi Y; Nishikubo M; Nishioka Y; Tane S; Kitamura Y; Sudo T; Sakuma T; Yoshimura M
Thorac Cancer; 2020 Sep; 11(9):2561-2569. PubMed ID: 32691982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
